SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1

CUSIP: 84763AAB4

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Debt / NOTE 2.750%12/1
Market price (% of par)
185.6%
Total 13F principal
$35,934,000
Principal change
-$68,040,000
Total reported market value
$66,778,279
Number of holders
9
Value change
-$102,030,902
Number of buys
2
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 84763AAB4?
CUSIP 84763AAB4 identifies 84763AAB4 - SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1 as of Q4 2017

As of 31 Dec 2017, SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1 was held by 9 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $35,934,000 in principal (par value) of the bond. The largest 9 bondholders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, SONORA INVESTMENT MANAGEMENT, LLC, CSS LLC/IL, WOLVERINE ASSET MANAGEMENT LLC, ASHFORD CAPITAL MANAGEMENT INC, CREDIT SUISSE AG/, OAKTREE CAPITAL MANAGEMENT LP, SEI INVESTMENTS CO, and ROYAL BANK OF CANADA. This page lists 9 institutional bondholders reporting positions for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.